Search

everythinglearnresearchcommunity

for

Search:↓

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Minoxidil can cause dangerous fluid buildup around the heart.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Dermatologists should screen for and manage psychological issues in patients with skin conditions to improve their quality of life.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Lupus can cause hair loss and nail changes, with treatments available for both.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.